Recombinant DNA Advisory Committee - 10/16/90 
National Institutes of Health staff: 
W. French Anderson, NHLBI 
Christine Ireland, OD 
Kris Kiser, OD 
Becky Lawson, OD 
Erwin Peters , OD 
Others: 
Arindam Bose, Pfizer Central Research 
Thomas L. Copmann, Pharmaceutical Manufacturers Association 
Ron Evans, Environmental Protection Agency 
Carol Ezzell, BioWorld 
Mark Foglesong, Eli Lilly and Company 
Joseph R. Fordham, Nova Nordisk Bioindustrials, Inc. 
Jeffrey Fox, ASM News and Biotechnology 
Rebecca J. Goldburg, Environmental Defense Fund 
Alan R. Goldhammer, Industrial Biotechnology Association 
Joseph Van Houten, Pharmaceutical Research Institute 
Doug Howell, McDermitt, Will & Emery Law Firm 
Dorothy S. Jessop, Department of Agriculture 
Attila T. Kadar, Food and Drug Administration 
Laura Leach, Animal Health Institute 
Rachel E. Levinson, Office of Science and Technology Policy 
Mark Lewis, Hill and Knowlton 
Tony Lubiniecki, SmithKline-Beecham Pharmaceuticals 
William H. McMullen, Nova Nordisk Bioindustrials, Inc. 
Margaret Mellon, National Wildlife Federation 
John H. Payne, Department of Agriculture 
Amy Silliman, Science Magazine 
Larry Thompson, Washington Post 
Manuel Valenzuela, Meharry Medical College 
Erik J. G. Vandelinde, Netherlands Embassy 
Lisa White, Blue Sheet 
John R. Wood, Department of Agriculture 
Recombinant DNA Research, Volume 14 
[337] 
